drugset / Trial / NCT01018368
Study of VX-770 and Rifampin in Healthy Male Subjects
Non-randomizedCrossoverOpen-labelTreatment
Summary
The objectives of this study are to evaluate the effects of multiple doses of rifampin on the single-dose pharmacokinetics of VX 770.
Timeline
- Start
- 2009-11
- Primary completion
- 2010-03
- Completion
- 2010-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ivacaftor | Other / unclassified | 150 mg | Oral |
| Subject | Rifampin | Small molecule | 600 mg | Oral |